TEL: +86-57186608701//81389219/89712897   Email:admin@safecare.com.cn
简体中文简体中文
Home » News » Company News » Congratulations to UK CTDA approval of our Safecare Covid-19 antigen

Congratulations to UK CTDA approval of our Safecare Covid-19 antigen

Views: 1     Author: Site Editor     Publish Time: 2022-07-19      Origin: Site

1.png

On July 14,2022, Safecare Covid-19 antigen Rapid Test Kit for Self-Testing,manufactured by us was successfully approved by CTDA in the United Kingdom, which means that our Safecare Covid-19 antigen Rapid Test Kit  can be legally sold in the British market. Coronavirus Test Device Approvals, referred to as CTDA, is a regulation issued by the British government for Covid-19 testing reagents which means the companies need to register and pass the CTDA approval before they can sell Covid-19 testing products in the UK. We are the third approved company in China after the British government implemented new registration regulations for covid-19 testing. It is also another international authoritative certification after the product obtained the self-test CE approval.

CTDA application outcome - COVID-19 Antigen Rapid


Quick Links

Product Category

Contact Us

Address : Bldg 2, No 2628 Yuhang

tang RD,Hangzhou, 311121 China

Tel: (+86) 57186608701//81389219
/89712897
Email: admin@safecare.com.cn
Send Us A Message
 Copyrights 2022 Safecare Biotech(Hangzhou)Co.,Ltd